STOCK TITAN

IQVIA Celebrates Wendy Stewart and Susan Barnes, Winners of Healthcare Businesswoman's Association Luminary and Rising Star Awards

Rhea-AI Impact
(No impact)
Rhea-AI Sentiment
(Very Positive)
Tags
IQVIA (NYSE:IQV) celebrates Wendy Stewart and Susan Barnes for winning the Healthcare Businesswoman's Association Luminary and Rising Star Awards. Wendy, president of Clinical Operations, led teams in delivering COVID vaccine trials. Susan, senior director of IQVIA Biotech Strategic Operations, drove innovation and mentorship in the business. Both represent IQVIA's values and serve as role models for employees.
IQVIA (NYSE:IQV) celebra Wendy Stewart e Susan Barnes per avere vinto i premi Luminary e Rising Star dell'Healthcare Businesswoman's Association. Wendy, presidente delle Operazioni Cliniche, ha guidato team nel condurre sperimentazioni per il vaccino contro il COVID. Susan, direttrice senior delle Operazioni Strategiche Biotech di IQVIA, ha promosso innovazione e mentorship nell'azienda. Entrambe rappresentano i valori di IQVIA e sono modelli di riferimento per i dipendenti.
IQVIA (NYSE:IQV) celebra a Wendy Stewart y Susan Barnes por ganar los premios Luminary y Rising Star de la Asociación de Mujeres Empresarias del Sector Salud. Wendy, presidenta de Operaciones Clínicas, lideró equipos en la realización de ensayos de vacunas COVID. Susan, directora senior de Operaciones Estratégicas Biotech de IQVIA, impulsó la innovación y el mentorazgo en la empresa. Ambas representan los valores de IQVIA y sirven como modelos a seguir para los empleados.
IQVIA (NYSE:IQV)는 Wendy Stewart와 Susan Barnes가 헬스케어 비즈니스우먼 협회의 Luminary 및 Rising Star 상을 수상한 것을 축하합니다. 클리니컬 운영 총괄인 Wendy는 코로나바이러스 백신 시험을 주도한 팀을 이끌었으며, IQVIA Biotech 전략 운영의 시니어 디렉터인 Susan은 기업 내에서 혁신과 멘토링을 추진하였습니다. 두 사람 모두 IQVIA의 가치를 대표하며 직원들에게 롤 모델이 되고 있습니다.
IQVIA (NYSE:IQV) célèbre Wendy Stewart et Susan Barnes pour avoir remporté les prix Luminary et Rising Star de l'Association des Femmes d'Affaires en Santé. Wendy, présidente des opérations cliniques, a dirigé des équipes dans la réalisation des essais de vaccins contre le COVID. Susan, directrice senior des opérations stratégiques de IQVIA Biotech, a été à l'avant-garde de l'innovation et du mentorat dans l'entreprise. Elles incarnent toutes deux les valeurs de IQVIA et sont des modèles pour les employés.
IQVIA (NYSE:IQV) feiert Wendy Stewart und Susan Barnes für ihre Auszeichnungen mit den Luminary und Rising Star Awards der Healthcare Businesswoman's Association. Wendy, Präsidentin der Klinischen Betriebsführungen, leitete Teams bei der Durchführung von COVID-Impfstoffstudien. Susan, Senior Direktorin für strategische Operationen bei IQVIA Biotech, förderte Innovation und Mentorship im Unternehmen. Beide repräsentieren die Werte von IQVIA und sind Vorbilder für die Mitarbeiter.
Positive
  • None.
Negative
  • None.

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- IQVIA (NYSE:IQV) today announced that Wendy Stewart, president of Clinical Operations at IQVIA, and Susan Barnes, senior director of IQVIA Biotech Strategic Operations, have been honored with the Healthcare Businesswoman's Association Luminary and Rising Star Awards, respectively.

Wendy earned the award for her remarkable contributions to the healthcare industry, including her efforts in leading the teams responsible for the record-breaking delivery of COVID vaccine trials. She currently leads a diverse and global organization of over 12,000 employees that is accountable for overall operational delivery for clinical trials across 60+ countries. In addition she has made significant contributions to advancing opportunities for women in Clinical Operations and, consequently, six of seven senior leadership positions within the Clinical Operations Leadership Team are held by women.

Susan was honored for her leadership, as well as her reputation as a skilled innovator. Over the last nine years Susan has driven significant innovation in how we deliver to our biotech and pharma customers as well as substantial improvements to our operations. Susan has used her position and experiences as a mentor and role model to women throughout the business.

“Wendy and Susan represent the exceptional talent we have in the organization, exemplifying IQVIA’s values and serving as role models for all IQVIA employees,” said IQVIA Chairman and CEO Ari Bousbib. “Their unique passion for healthcare, innovative spirit and dedication to our mission has improved healthcare outcomes across the globe.”

Wendy, Susan and other 2024 HBA award winners will be honored at HBA’s Women of the Year Annual Conference in New York City, May 10.

About the Awards

The Healthcare Businesswomen’s Association (HBA) is a global organization committed to furthering the advancement and impact of women within healthcare. Its annual Luminary Award recognizes seasoned and talented professionals who have significantly impacted the healthcare industry by leading and serving as role models, actively mentoring others and driving impactful progress at their organizations and within the industry. The Rising Star Award recognizes individuals who have made significant contributions to their respective company, exemplified strong and innovative leadership, and have worked with others to help them achieve their goals. For more information, visit https://www.hbanet.org/.

About IQVIA

IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise. IQVIA Connected Intelligence™ delivers powerful insights with speed and agility — enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 87,000 employees, IQVIA conducts operations in more than 100 countries.

IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.iqvia.com.

Kerri Joseph, IQVIA Investor Relations (kerri.joseph@iqvia.com)

+1.610.244.3020

Trent Brown, IQVIA Media Relations (trent.brown@iqvia.com)

+1.919.780.3221

Source: IQVIA

FAQ

Who won the Healthcare Businesswoman's Association Luminary and Rising Star Awards at IQVIA?

Wendy Stewart and Susan Barnes.

What is Wendy Stewart's role at IQVIA?

President of Clinical Operations.

What achievements led Wendy Stewart to win the award?

Leading teams in delivering record-breaking COVID vaccine trials and advancing opportunities for women in Clinical Operations.

Who is Susan Barnes at IQVIA?

Senior director of IQVIA Biotech Strategic Operations.

What did Susan Barnes do to earn the award?

Drove significant innovation in delivering to biotech and pharma customers and improved operations.

When will Wendy, Susan, and other 2024 HBA award winners be honored?

At HBA's Women of the Year Annual Conference in New York City on May 10.

IQVIA Holdings Inc.

NYSE:IQV

IQV Rankings

IQV Latest News

IQV Stock Data

40.66B
179.80M
0.92%
92.3%
1.59%
Offices of All Other Miscellaneous Health Practitioners
Health Care and Social Assistance
Link
United States of America
DURHAM

About IQV

quintiles and imshealth have merged together to form the new quintilesims. each wanting to bring something new to customers, we deliver integrated information and technology solutions to drive healthcare forward. quintilesims has approximately 50,000 employees conducting operations in more than 100 countries, dedicated to helping our clients improve their clinical, scientific and commercial results. as a global leader in protecting individual patient privacy, quintilesims uses healthcare data to deliver critical, real-world disease and treatment insights. to learn more, visit www.quintilesims.com